# Contact Sermorelin Research: Editorial Correspondence

> Contact Sermorelin Research with editorial corrections or citation questions about the sermorelin (GHRH(1-29)) literature. Editorial only — no medical or sales inquiries.

Editorial correspondence about the GHRH(1-29) record — corrections, citation questions, and sourcing notes.

## Editorial correspondence

Use the form below for editorial matters only: a correction to a citation, a question about how we read a study, or a pointer to a relevant paper we may have missed. We read every note about the accuracy of the sermorelin record, because a citation that does not check out is a defect we want to fix.

We cannot answer medical questions, and we will not. This site does not provide clinical guidance, does not recommend doses, and has no clinicians to consult. If you are looking for medical advice about growth-hormone therapy, a licensed healthcare professional is the correct source — not an editorial digest.

## What we cannot help with

We do not sell sermorelin or any other compound, do not maintain a store, and cannot direct you to a vendor, a price, or a source — the [frequently asked questions](/faq) explain the research-only scope of this project. We hold no inventory and process no orders.

For anything outside editorial correspondence — purchasing, prescriptions, dosing, or personal health decisions — this is not the right address. What we can do is account for any figure on this site by pointing you to the study behind it. That is the whole remit: a verifiable reading of the published GHRH(1-29) literature.

---

A forensic reading board for the GHRH(1-29) record — every endocrine figure, half-life, and metabolite logged to the study that measured it, the body-composition data filed where it belongs as tesamorelin, and the literature treated like an analyte read against a threshold: present and cited, or marked absent; no clinic behind the board and nothing here dosed, dispensed, or sold.